(Q39206794)

10 September 2017

Immunologic reactivity in patients with primary operable breast cancer (English)

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

10 September 2017

1 reference

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

4 March 2023

7

Oettgen HF

1 reference

10 September 2017

H. J. Wanebo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A304759

4 March 2023

H. T. Thaler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A304759

4 March 2023

J. A. Hansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A304759

4 March 2023

P. P. Rosen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A304759

4 March 2023

G. F. Robbins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A304759

4 March 2023

J. A. Urban

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A304759

4 March 2023

R. A. Good

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A304759

4 March 2023

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

10 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

4 March 2023

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

4 March 2023

1 reference

10 September 2017

41

1 reference

10 September 2017

84-94

1 reference

10 September 2017

1

1 reference

Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells.

10 September 2017

1

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization

4 March 2023

2

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Cellular responses to autologous breast cancer tissue:Correlation with stage and lymphoreticuloendothelial reactive

4 March 2023

3

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Cellular hypersensitivity to breast cancer.Assessment by a leukocyte migration procedure

4 March 2023

4

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Lymphocyte reactivity in cancer patients: Correlation with tumor histology and clinical stage

4 March 2023

6

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Impaired immunologic reactivity and recurrence following cancer surgery

4 March 2023

10

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Immunologic competence of regional lymph nodes in patients with breast cancer

4 March 2023

11

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Studies concerning the regional lymph node in cancer. III. Response of regional lymph node cells from breast and colon cancer patients to PHA stimulation

4 March 2023

12

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Studies concerning the regional lymph node in cancer. VII. Thymidine uptake by cells from nodes of breast cancer patients relative to axillary location and histopathologic discriminants

4 March 2023

13

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Cancer of the breast: Size of neoplasm and prognosis

4 March 2023

14

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Cellular immunity to human breast carcinoma

4 March 2023

15

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Demonstration of cell-mediated immunity to human neoplasms of various histological types

4 March 2023

16

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Suppression of the tuberculin response in malignant disease

4 March 2023

17

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Significance of Axillary Macrometastases and Micrometastases in Mammary Cancer

4 March 2023

19

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

DECLINING TUBERCULIN SENSITIVITY WITH ADVANCING AGE.

4 March 2023

20

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells

4 March 2023

21

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck

4 March 2023

22

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Peripheral Blood Lymphocytes and Breast Cancer

4 March 2023

23

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Tuberculin allergy and cancer risk

4 March 2023

24

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

The delayed hypersensitivity response in primary breast carcinoma as an index of host resistance

4 March 2023

25

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

The prognostic significance of peripheral lymphocyte counts in patients with breast carcinoma

4 March 2023

27

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

The delayed hypersensitivity reaction in breast cancer.

4 March 2023

32

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors.3. The frequency, duration, and cross reactivity of this phenomenon in patients with breast cancer, and its correlation with survival

4 March 2023

34

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma

4 March 2023

35

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer

4 March 2023

36

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters

4 March 2023

37

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

T-cell deficiency in patients with squamous cell cancer of the head and neck

4 March 2023

38

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

T and B lymphocytes in breast cancer stage relationship and abrogation of T-lymphocyte depression by enzyme treatment in vitro

4 March 2023

40

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

Reduced lymphocyte transformation in breast cancer

4 March 2023

41

1 reference

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

https://api.crossref.org/works/10.1002/1097-0142(197801)41:1%3C84::AID-CNCR2820410113%3E3.0.CO;2-X

4 March 2023

Identifiers

10.1002/1097-0142(197801)41:1<84::AID-CNCR2820410113>3.0.CO;2-X

1 reference

10 September 2017

1 reference